Page last updated: 2024-11-05

triamterene and Porphyrias

triamterene has been researched along with Porphyrias in 1 studies

Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.

Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Motley, RJ1

Other Studies

1 other study available for triamterene and Porphyrias

ArticleYear
Pseudoporphyria due to dyazide in a patient with vitiligo.
    BMJ (Clinical research ed.), 1990, Jun-02, Volume: 300, Issue:6737

    Topics: Aged; Antihypertensive Agents; Drug Combinations; Humans; Hydrochlorothiazide; Male; Porphyrias; Tri

1990